Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...

The chordae tendineae (CT), often referred to as the “heart strings,” are thin, tendinous structures that connect the heart ...

Mitral Valve Regurgitation: The valve doesn’t close completely, allowing blood to leak backward into the atrium. Mitral Valve Stenosis: The valve becomes too narrow, restricting proper blood flow.

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical ... System in treating patients with [mitral regurgitation],” 4C Medical CEO Saravana Kumar ...

TRILUMINATE's primary endpoint was a hierarchical composite of death from any cause or tricuspid valve surgery, ...

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment management firm ...

Mitral valve annuloplasty devices are expected to see the highest growth in the region. Increased investments in healthcare infrastructure, advancements in medical research, and a growing elderly ...

Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until ...

The Carillon device is designed to restore natural mitral valve function without damaging ... have shown the Carillon therapy reduces mitral regurgitation, improves quality of life, and has ...

Dexfenfluramine, aka Redux (also called “fen-phen” in combination with phentermine), was sold in the 1990s until it was ...

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System Cardiac Dimensions, a leader in minimally invasive treatments ...